Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
ConditionOsteoarthritis Knee Pain
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age40+
SponsorSaol Therapeutics Inc
About this trial
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Eligibility criteria
Qualifiers
Male or female patients ≥ 40 years of age
Body Mass Index (BMI) limits
Chronic knee pain resulting from osteoarthritis
Kellgren-Lawrence Grade 2 (mild) or Grade 3 (moderate)
Disqualifiers
Non-OA inflammatory arthritis
Confounding elements
Lower limb amputation.
Specified alternate historic treatments
Trial design
Treatments tested in this trial
- SL1002
- Normal Saline
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov